| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |